1187451-28-0 Usage
Uses
Used in Pharmaceutical Industry:
(4-(Thiazol-2-yl)phenyl)MethanaMine hydrochloride is used as a key intermediate for the synthesis of various drugs and bioactive molecules, particularly in the development of antineoplastic and antiviral medications. Its unique chemical structure allows for the creation of compounds with potential therapeutic effects against cancer and viral infections.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4-(Thiazol-2-yl)phenyl)MethanaMine hydrochloride is utilized as a starting material for the design and synthesis of new pharmaceutical compounds. Its versatility and reactivity make it an essential component in the discovery of innovative drug candidates with improved efficacy and safety profiles.
Used in Drug Development:
The hydrochloride salt form of (4-(Thiazol-2-yl)phenyl)MethanaMine offers improved solubility and stability compared to the free base form, making it more suitable for pharmaceutical applications. This enhanced stability is crucial for the development of drugs with better pharmacokinetic properties, ultimately leading to more effective treatments for various diseases.
Overall, (4-(Thiazol-2-yl)phenyl)MethanaMine hydrochloride is an indispensable compound in the field of drug development and pharmaceutical research, playing a vital role in the creation of new and improved therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1187451-28-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,4,5 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1187451-28:
(9*1)+(8*1)+(7*8)+(6*7)+(5*4)+(4*5)+(3*1)+(2*2)+(1*8)=170
170 % 10 = 0
So 1187451-28-0 is a valid CAS Registry Number.
1187451-28-0Relevant articles and documents
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA
-
Page/Page column 104, (2012/02/15)
The present invention is to provide a medical composition for the treatment or prophylaxis of glaucoma which comprises a pyridylaminoacetic acid compound represented by the formula (1): wherein R1, R2 and R3 each independe
